Who To Contact

Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207

Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com

Clinical Trial ID:

EAP: Expanded Access Use of Vorasidenib, for the treatment of IDH1 and IDH2 mutated Glioma

Status

Open

Conditions

Other

Phases

Pilot

Age Group

Adult

Main Investiagtor

Cavaliere, Robert

Practice

CNS

Scope

National

Participating Institutions

Baptist MD Anderson Cancer Center

Secondary Trial ID Number

VORA-EAP-01

Keywords

Treatment